Drug Discovery

Science News

Dr. Jeremiah Stamler, 'the father of preventive cardiology,' dies at 102
Impact of the COVID-19 Pandemic on Cardiovascular Science
Comparative First-Line Effectiveness and Safety of ACE (Angiotensin-Converting Enzyme) Inhibitors and Angiotensin Receptor Blockers: A Multinational Cohort Study
2020 AHA/ACC Consensus Conference on Professionalism and Ethics
Preclinical Models of Cancer Therapy–Associated Cardiovascular Toxicity

Journals

Tenecteplase Improves Door‐to‐Needle Time in Real‐World Acute Stroke Treatment
Hypertension Pharmacological Treatment in Adults: A World Health Organization Guideline Executive Summary
Systems Approach to Integrating Preclinical Apolipoprotein E-Knockout Investigations Reveals Novel Etiologic Pathways and Master Atherosclerosis Network in Humans
Insights Into the Role of Tetrahydrobiopterin Deficiency in the Pathogenesis of Gestational Hypertension
Scavenging Free Iron Reduces Arteriolar Microvasospasms After Experimental Subarachnoid Hemorrhage

Continuing Education

Scientific Sessions attendees looking at a phone in front of giant Heart and Torch stature

Meet us in November in Boston or online from anywhere through our virtual platform for the global cardiovascular event of the year! Reconnect with colleagues, experience breakthrough cardiovascular basic, clinical and population science updates, and immerse yourself in innovative solutions designed to help you in your daily practice at the American Heart Association’s Scientific Sessions 2021.

  • Enjoy instant access to leaders in the field and the latest discoveries in cardiovascular science and medicine.

  • Reconnect and collaborate with global thought leaders from over around the world.

  • Experience programming designed with your needs in mind with 27 programming communities.
  • CE and MOC credits available.

  • And more!

Don’t forget! AHA Professional Members receive the best rates for attending Scientific Sessions. Learn more about this and other benefits by becoming an AHA Professional Member.

The ATVB Council focuses on arteriosclerosis, thrombosis and vascular biology. The council advances research, addresses prevention, improves diagnosis and treatment, and works actively with other organizations. It shares reliable information through its annual conference, awards and lectures, and in the AHA’s journal, Arteriosclerosis, Thrombosis, and Vascular Biology.


The CLCD Council supports AHA objectives in clinical cardiology, promotes excellent clinical care, and fosters professional development and education for clinical cardiologists. Through council-sponsored symposia, panels, and scientific conferences, members can access and interpret new developments in the field and promote clinical cardiology to professional and lay audiences.


The GPM Council seeks to advance discovery and translation of biological insights from genetics and omics technologies to improve cardiovascular and brain health through better risk prediction, treatment and prevention for patients. Our expertise spans genetics, genomics, genomic medicine, epigenetics, transcriptomics, metabolomics, proteomics, microbiome, bioinformatics, computational science, and population health.


TIPS 3 Results

Principal investigator Prem Pais, MD summarizes the results of TIPS-3, which tested the use of a polypill for primary prevention of cardiovascular disease.

American Heart Association Professional Members

Enjoy instant benefits!

  • Free Online Access to AHA Scientific Journals
  • Affiliate with our 16 Scientific Councils
  • Discounts on Scientific Conference Registration and Online Courses